GlassScriptPhysician profile
Kristen Mailand
NPI 1720468457
$934.24
in general payments reported to CMS, 2019-2025
18 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $16.19 · 2022: $108 · 2023: $49.07 · 2024: $211 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $635.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $191.41 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $162.01 | 2019-2025 | Wegovy |
| Pfizer INC. | $118.44 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $97.23 | 2019-2025 | Capvaxive |
| Amgen INC. | $51.06 | 2019-2022 | |
| Lilly USA, LLC | $43.01 | 2024 | Jardiance, Zepbound, Mounjaro |
| Kowa Pharmaceuticals America, INC. | $34.64 | 2024-2025 | Zoryve |
| Biohaven Pharmaceutical Holding Company LTD. | $28.74 | 2022 | |
| Abbott Laboratories | $26.69 | 2023 | Freestyle Libre 3 |
| Eisai INC. | $26.35 | 2024 | |
| Amarin Pharma, INC. | $24.53 | 2019 | |
| Dexcom, INC. | $22.38 | 2023 | Dexcom G6 Transmitter |
| Avvisto Therapeutics, LLC | $21.10 | 2024 | Cycloset |
| Seqirus USA INC | $20.00 | 2019 | |
| Abbvie INC. | $18.97 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $17.53 | 2025 | Immunocap |
| Otsuka America Pharmaceutical, INC. | $15.55 | 2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Mailand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.